STAT

APRIL 1, 2025

In 2024, total U.S. spending on prescription drugs was almost $800 billion. Although low-cost generic drugs filled 91% of all prescriptions, the 9% of prescriptions filled with a branded medicine accounted for 84% of drug spending.

Prescription Filling 277

Prescription Filling Drug Pricing Drug Development 277

Putting Patients First Blog

SEPTEMBER 3, 2024

Overall, while the NHC appreciates CMS’ intent to streamline the data submission process and make it more accessible, we encourage ongoing dialogue and adjustments to ensure that the process remains patient-centered, efficient, and capable of capturing the full spectrum of information necessary to inform meaningful drug price negotiations.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling Communication 52

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). An assessment of regulatory interpretation of qualifying single-source drugs in Medicare negotiation.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Ramblings of a pharmacist

FEBRUARY 16, 2022

I’ll also note that I’m not certain that the “Pharmacy” revenue is ONLY prescription fills. Digest per prescription revenue figure is believable (it’s also down about $6 since I started paying attention to the Digest , hence my annoyance at people that blame pharmacists for “skyrocketing drug prices.”

Independent Pharmacies 52

Independent Pharmacies Compounding Specialty Pharmacies Prescription Filling 52

Putting Patients First Blog

JANUARY 27, 2025

1 (February 14, 2023): 1023, [link] 10 Institute for Clinical and Economic Review, Assessment of Barriers to Fair Access Report , 2024, [link] Report-121924.pdf. 12 Mark Kyle and Natalie Keating, “Prior Authorization and Association with Delayed or Discontinued Prescription Fills,” Journal of Clinical Oncology 42, no.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Safe Biologics

MARCH 10, 2025

This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs vital for cancer treatment and popular new weight loss medications that have transformed the management of obesity and related conditions. What Will 2025 Mean for Medicare Drug Price Setting Under the IRA?

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130